Evidence map›Paper›PMID 42680822›Full record

ReviewLeukemia2026

Defining and predicting disease progression in myeloproliferative neoplasms: a proposed biomarker-driven approach.

Raajit K Rampal, Richard Winneker, Andrew Kuykendall, Laura C Michaelis, Ghaith Abu-Zeinah, Steffen Koschmieder, Jan Philipp Bewersdorf, Zi Yun Ng, Gabriella Hobbs, Bridget Marcellino and 9 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Leukemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Raajit K RampalLeukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. rampalr@mskcc.org.ORCID http://orcid.org/0000-0002-0355-6368
Richard WinnekerMPN Research Foundation, Chicago, IL, USA.
Andrew KuykendallMalignant Hematology Department, H Lee Moffitt Cancer Center, Tampa, FL, USA.
Laura C MichaelisDivision of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.ORCID http://orcid.org/0000-0002-1798-9658
Ghaith Abu-ZeinahWeill Cornell Medical College, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-1881-3670
Steffen KoschmiederDepartment of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, University of Aachen, Aachen, Germany.ORCID http://orcid.org/0000-0002-1011-8171
Jan Philipp BewersdorfSection of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-3352-0902
Zi Yun NgDepartment of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0001-5050-1223
Gabriella HobbsDivision of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-0199-9333
Bridget MarcellinoTisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0001-8590-6175
Linda ResarDivision of Hematological Malignancies and Bone Marrow Transplantation, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-4004-7060
Joseph ScanduraWeill Cornell Medical College, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-9525-143X
Anand PatelSection of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-0296-8686
John MascarenhasTisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0002-8400-0483
Aaron GerdsCleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-3422-1309
Douglas TremblayTisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Shane MayackCenter for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Andriy DerkachLeukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Florian H HeidelHematology, Hemostasis, Oncology and Cell Therapy, Hannover Medical School (MHH), Hannover, Germany.ORCID http://orcid.org/0000-0003-2438-1955

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42680822

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.